Compositions, kits, and methods for crispr-based quantification of nucleic acids

WO2026136567A2PCT designated stage Publication Date: 2026-06-25SAFEVIGEN INC

Patent Information

Authority / Receiving Office
WO · WO
Patent Type
Applications
Current Assignee / Owner
SAFEVIGEN INC
Filing Date
2025-12-17
Publication Date
2026-06-25

Smart Images

  • Figure US2025060155_25062026_PF_FP_ABST
    Figure US2025060155_25062026_PF_FP_ABST
Patent Text Reader

Abstract

Compositions, kits, methods, and systems for CRISPR-based quantification of nucleic acids are described herein.
Need to check novelty before this filing date? Find Prior Art